BR112019001054A2 - desinfetantes tópicos emolientes - Google Patents

desinfetantes tópicos emolientes

Info

Publication number
BR112019001054A2
BR112019001054A2 BR112019001054-8A BR112019001054A BR112019001054A2 BR 112019001054 A2 BR112019001054 A2 BR 112019001054A2 BR 112019001054 A BR112019001054 A BR 112019001054A BR 112019001054 A2 BR112019001054 A2 BR 112019001054A2
Authority
BR
Brazil
Prior art keywords
emollient
topical disinfectants
molecular iodine
emollient topical
disinfectants
Prior art date
Application number
BR112019001054-8A
Other languages
English (en)
Inventor
Kessler Jack
C. Litzinger David
Rhodes Christopher
M. Cerro Andrew
Original Assignee
Iogen, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iogen, Llc filed Critical Iogen, Llc
Publication of BR112019001054A2 publication Critical patent/BR112019001054A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

a presente invenção refere-se a uma composição tópica emoliente de matéria que contém iodo molecular com uma pressão de vapor efetiva reduzida. em modalidades específicas, a composição reduz a perda de iodo molecular para a atmosfera sob condições de armazenamento após aplicação a tecido mamífero.
BR112019001054-8A 2016-07-21 2017-07-19 desinfetantes tópicos emolientes BR112019001054A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662365035P 2016-07-21 2016-07-21
US62/365,035 2016-07-21
PCT/US2017/042726 WO2018017645A1 (en) 2016-07-21 2017-07-19 Emollient topical disinfectants

Publications (1)

Publication Number Publication Date
BR112019001054A2 true BR112019001054A2 (pt) 2019-04-30

Family

ID=60996082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019001054-8A BR112019001054A2 (pt) 2016-07-21 2017-07-19 desinfetantes tópicos emolientes

Country Status (10)

Country Link
US (2) US11596648B2 (pt)
EP (1) EP3487509A4 (pt)
JP (2) JP2019531331A (pt)
KR (1) KR20190123716A (pt)
CN (1) CN110072532A (pt)
AU (2) AU2017300497A1 (pt)
BR (1) BR112019001054A2 (pt)
CA (1) CA3031447A1 (pt)
MX (1) MX2019000902A (pt)
WO (1) WO2018017645A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220211751A1 (en) * 2020-08-13 2022-07-07 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
WO2023053137A1 (en) * 2021-09-28 2023-04-06 Kejriwal Anil Molecular iodine, alcohol, and propanediol based formulation and its application for relieving body odor
WO2023084536A1 (en) * 2021-11-09 2023-05-19 Kejriwal Anil Molecular iodine and butylene glycol based formulation and its application in acne care
WO2023084535A1 (en) * 2021-11-09 2023-05-19 Kejriwal Anil Molecular iodine and propanediol based formulation and its application in facial acne cleansing
WO2023084537A1 (en) * 2021-11-09 2023-05-19 Kejriwal Anil Molecular iodine and alcohol based formulation and its application in air sanitization/disinfection
WO2023119325A1 (en) * 2021-12-20 2023-06-29 Kejriwal Anil Molecular iodine and citronella oil based formulation, and its application as mosquito repellent
WO2023119321A1 (en) * 2021-12-20 2023-06-29 Kejriwal Anil Molecular iodine and propanediol based formulation and its application in oral mucosal and intranasal antisepsis
WO2023119323A1 (en) * 2021-12-20 2023-06-29 Kejriwal Anil Molecular iodine, alcohol, and propanediol based formulation and its application in relieving foot odor
WO2023119324A1 (en) * 2021-12-20 2023-06-29 Kejriwal Anil Molecular iodine and alcohol based formulation and its application in antisepsis and disinfection
WO2023119322A1 (en) * 2021-12-20 2023-06-29 Kejriwal Anil Molecular iodine and alcohol based formulation and its application in lavatory surface sanitization and disinfection

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1896171A (en) * 1932-02-20 1933-02-07 Harry John Charles Iodine preparation and process of making the same
US2550622A (en) 1947-07-11 1951-04-24 Benjamin Clayton Ointment base and iodine ointment
CH443774A (de) 1963-05-30 1967-09-15 Ciba Geigy Mittel zur Bekämpfung phytopathogener Mikroorganismen
US3950261A (en) 1975-05-29 1976-04-13 American Cyanamid Company Anhydrous liquid iodophor solution
US4954351A (en) * 1983-03-02 1990-09-04 Euroceltique S.A. Method of producing standardized povidone iodine preparations and such preparations
JPS60185720A (ja) 1985-02-01 1985-09-21 エムデイ−　コ−ポレ−シヨン 沃素含有組成物を含む医療用殺菌剤およびその製造方法
US4937072A (en) 1986-05-12 1990-06-26 Kessler Jack H In situ sporicidal disinfectant
US5013859A (en) 1988-04-21 1991-05-07 Globus Alfred R Iodophor
USRE36605E (en) 1988-09-06 2000-03-07 Symboollon Corporation Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, an iodide compound, a peroxide and a surfactant
US5370815A (en) 1988-09-06 1994-12-06 Kessler; Jack H. Viscous epidermal cleaner and disinfectant
US5227161A (en) 1988-09-06 1993-07-13 Symbollon Corporation Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, iodide compound and surfactant
US5629024A (en) 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition
US5849291A (en) 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
US5639481A (en) 1994-10-17 1997-06-17 Symbollon Corporation Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine
US5648075A (en) 1994-10-17 1997-07-15 Symbollon Corporation Iodine based germicidal composition
US5607699A (en) 1995-05-12 1997-03-04 Becton Dickinson And Company Non-aqueous emiollient iodophor formulations
CA2183415C (en) 1995-09-01 2000-10-10 Minh Q. Hoang A new skin preparation composition
US5962029A (en) 1996-07-05 1999-10-05 Symbollon Corporation Iodine germicides that continuously generate free molecular iodine
US6261577B1 (en) 1997-07-16 2001-07-17 Symbollon Corporation Non-staining topical iodine composition and method
US6015836A (en) 1997-10-28 2000-01-18 Martin; Howard Chemical disinfectant employing dual chain quaternary ammonium compounds with iodine
US5885592A (en) 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
US6248335B1 (en) 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
US5897872A (en) 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
US6432426B2 (en) 1998-11-30 2002-08-13 Symbollon Corporation Non-staining topical iodine composition and method
US6228354B1 (en) 1999-07-02 2001-05-08 Allegiance Corporation Water resistant film-forming antimicrobial skin-preparation
KR100386447B1 (ko) 1999-12-23 2003-06-02 주식회사 하이닉스반도체 반도체장치의 커패시터 제조방법
US6902747B1 (en) 2000-05-03 2005-06-07 Westfaliasurge, Inc. Iodine-propylene glycol teat dip
US20030026852A1 (en) 2001-03-27 2003-02-06 Symbollon Corporation Molecular iodine pharmaceutical composition
EP1404609B1 (en) 2001-05-23 2011-08-31 Cohen, Ben Z. Accurate dosing pump
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US20040091553A1 (en) 2002-11-12 2004-05-13 West Agro, Inc Composition and method for mammary disinfection during winter conditions
US9114156B2 (en) 2002-12-30 2015-08-25 Aplicare, Inc. Enhanced antimicrobial skin preparation
JP4084329B2 (ja) 2004-03-31 2008-04-30 小林製薬株式会社 液状組成物およびその製造方法
JP2005306764A (ja) 2004-04-20 2005-11-04 Nippo Kagaku Kk ヨウ素−シクロデキストリン溶液の製造方法
US20060280809A1 (en) 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
US20090017139A1 (en) 2007-07-12 2009-01-15 Jack Kessler Iodine therapy dosing for treating medical conditions
JP5448381B2 (ja) 2007-07-19 2014-03-19 トーメー商事株式会社 ヨウ素迅速放出材およびその製造方法
US8808722B2 (en) 2010-06-29 2014-08-19 3M Innovative Properties Company Stable antiseptic compositions and methods
JP6203172B2 (ja) 2011-03-25 2017-09-27 デラヴァル ホールディング エービー 低界面活性剤のヨウ素系局所殺菌剤
US20140219949A1 (en) 2011-06-22 2014-08-07 Jiangsu Deda Pharmaceuticals Co. Ltd Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
US9874555B2 (en) 2012-04-12 2018-01-23 Becton, Dickinson And Company Methods, systems, and devices for detecting and identifying microorganisms in microbiological culture samples
US10034899B2 (en) 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
CA2940428C (en) 2014-03-31 2023-03-28 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
WO2018053335A1 (en) 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method
AU2018253944B2 (en) 2017-04-21 2022-09-15 Dermaliq Therapeutics, Inc. Iodine compositions
US20220211751A1 (en) 2020-08-13 2022-07-07 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses

Also Published As

Publication number Publication date
CN110072532A (zh) 2019-07-30
RU2019104862A (ru) 2020-08-24
EP3487509A4 (en) 2020-06-17
RU2019104862A3 (pt) 2020-11-26
AU2017300497A1 (en) 2019-03-14
US20190381093A1 (en) 2019-12-19
JP2019531331A (ja) 2019-10-31
KR20190123716A (ko) 2019-11-01
AU2023203406A1 (en) 2023-06-29
JP2022116141A (ja) 2022-08-09
EP3487509A1 (en) 2019-05-29
TW201805009A (zh) 2018-02-16
WO2018017645A1 (en) 2018-01-25
MX2019000902A (es) 2020-09-03
US20240033286A1 (en) 2024-02-01
CA3031447A1 (en) 2018-01-25
US11596648B2 (en) 2023-03-07

Similar Documents

Publication Publication Date Title
BR112019001054A2 (pt) desinfetantes tópicos emolientes
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2018000106A1 (es) Moléculas de anticuerpo que se unen a cd45
CU20190058A7 (es) Composiciones de aminoácidos relacionadas con mejoras de la función hepática
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CU20170172A7 (es) 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos
BR112018004620A2 (pt) moduladores da expressão de kras
BR112015030543A2 (pt) glicerol formador de película para aplicação tópica
BR112014026109A2 (pt) composição para tratamento dos cabelos que compreende ésteres insaturados de poliol metatetizados
CL2018000107A1 (es) Moléculas de anticuerpo que se unen a cd79
BR112018010381A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
BR112015025854A2 (pt) flagelina de roseburia e modulação imunológica
BR112015027321A8 (pt) Compostos e composições para modular a expressão de apolipoproteína(a) e seus usos
CL2017002082A1 (es) Nuevas proteínas especificas para pioverdina y pioquelina
BR112015021352A2 (pt) composições antimicrobianas
CO7240372A2 (es) Formulaciones farmacéuticas tópicas no acuosas
BR112016002233A2 (pt) composições de adoçante
BR112018010357A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e alteradora da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento do cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
BR112015023387A2 (pt) composições lipídicas de racecodotril
BR112016028692A2 (pt) artigos que fornecem fragrâncias de longa duração
CO7250444A2 (es) Uso de seaprose para eliminar biopelículas bacterianas
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B25A Requested transfer of rights approved

Owner name: I2PURE CORP. (US)